The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
?9d2 T-cell activation (?dTCA) with ICT01 combined with azacitidine-venetoclax (AV) for older/unfit adults with newly diagnosed (ND) AML: Preliminary efficacy and dose selection in phase 1/2 study EVICTION.
 
Pierre Yves Dumas
No Relationships to Disclose
 
Abhishek Maiti
Research Funding - Celgene (Inst); Chimeric Therapeutics (Inst); CytoMed Therapeutics (Inst); Indapta Therapeutics (Inst); Lin BioScience (Inst)
 
Pierre Peterlin
No Relationships to Disclose
 
Daniel Morillo
Honoraria - Abbvie; GlaxoSmithKline; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - Janssen Oncology; Kite, a Gilead company; Roche/Genentech
 
Jose Miguel Torregrosa-Diaz
No Relationships to Disclose
 
Matthew Ulrickson
Consulting or Advisory Role - ADC Therapeutics; Autolus; Bristol-Myers Squibb/Celgene/Juno; Genentech; Kura Oncology; Stemline Therapeutics
Research Funding - Immunogen; Kite, a Gilead company
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Agustin Penedo
No Relationships to Disclose
 
Aude De Gassart
Employment - Imcheck Therapeutics
Stock and Other Ownership Interests - Imcheck Therapeutics
 
Emmanuel Valentin
Employment - Imcheck Therapeutics
Stock and Other Ownership Interests - Imcheck Therapeutics
 
Maelle Mairesse
Employment - Imcheck Therapeutics
Stock and Other Ownership Interests - Imcheck Therapeutics
 
Patrick Brune
Employment - Imcheck Therapeutics
Stock and Other Ownership Interests - Imcheck Therapeutics
 
Katrien Lemmens
Employment - Imcheck Therapeutics
Stock and Other Ownership Interests - Imcheck Therapeutics
 
Daniel Olive
Stock and Other Ownership Interests - Alderaan Biotechnology; Imcheck Therapeutics; Lurus Bio; Phosphogam; Stealth Biotherapeutics
Research Funding - Imcheck Therapeutics (Inst)
Expert Testimony - Alderaan Biotechnology
 
Stephan Braun
Employment - Imcheck Therapeutics
Stock and Other Ownership Interests - Imcheck Therapeutics
 
Naval Daver
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Abbvie; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; Immunogen; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; SERVIER; Shattuck Labs; Stemline/Menarini; Syndax; Trillium Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); FATE Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immunogen (Inst); Kite, a Gilead company (Inst); Novimmune (Inst); Pfizer (Inst); Servier (Inst); Trillium Therapeutics (Inst); Trovagene (Inst)
 
Sylvain Garciaz
Research Funding - Abbvie (Inst)
Expert Testimony - Bristol-Myers Squibb; Imcheck Therapeutics; Janssen; Sanofi; SERVIER
Travel, Accommodations, Expenses - Abbvie